Wednesday, December 12, 2018 9:43:56 PM
https://www.panmerseyapc.nhs.uk/document-store/electromagnetic-pulse-therapy-actipatch/
Fylde and Wyre Clinical Commissioning Group has agreed not to fund the prescribing of ActiPatch for the treatment of pain in Knee Osteoarthritis or Plantar Fasciitis, or for any other indication:
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=27&cad=rja&uact=8&ved=2ahUKEwjB7Y7d4pvfAhVi04MKHcQrCZM4FBAWMAZ6BAgDEAI&url=http%3A%2F%2Fwww.fyldeandwyreccg.nhs.uk%2Fdownload%2Fpolicies%2Fmedicines_management%2FActipatch-for-pain-management.pdf&usg=AOvVaw2KaqNSju8dVs0mqILOA0_v
rejected as a topic here:
https://www.sps.nhs.uk/topics/?status=Rejected
The device has been categorised as Grey on the traffic light system and the recommendation is not to prescribe on FP10.
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=30&cad=rja&uact=8&ved=2ahUKEwjB7Y7d4pvfAhVi04MKHcQrCZM4FBAWMAl6BAgBEAI&url=http%3A%2F%2Fmedicinesmanagement.doncasterccg.nhs.uk%2Fwp-content%2Fuploads%2F2018%2F09%2FT%40blet-Issue-5-2018-1.pdf&usg=AOvVaw3Whb1vBC1QtyuJUI8fQD_t
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM